$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage biopharmaceutical company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ciechanover Isaac E.Chief Executive Officer731,85911,014,478shares bought: 514,538 / shares sold: -571,057 SELLMay 17 20178 days ago
Clark Mitchall G.EVP & Chief R & QA Officer156,8732,360,939shares bought: 85,558 / shares sold: -14,080 STRONG BUYMay 17 20178 days ago
Gallagher Carol GiltnerDirector103,7411,561,302shares bought: 13,829 / shares sold: -4,735 STRONG BUYMay 17 20178 days ago
Haqq ChristopherEVP, R&D & Chief Scientific Of381,6845,744,344shares bought: 143,646 / shares sold: -64,806 STRONG BUYMay 17 20178 days ago
MCGRATH JOHNEVP & Chief Financial Officer113,7621,712,118shares bought: 100,141 / shares sold: -66,395 BUYMay 17 20178 days ago
Newell JoeChief Tech. Operations Officer7,500112,875shares bought: 7,500 / shares sold: 0 BUYApr 03 20172 months ago
Porter DerrellSVP, Head of Global Commercial00May 11 201714 days ago
Sofer GadEVP & Chief Strategy Officer266,5274,011,231shares bought: 190,045 / shares sold: -52,028 STRONG BUYMar 13 20172 months ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...Option ExerciseM0.007,698020,526
May 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...Option ExerciseM0.0093500
May 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...SellS15.272,00030,540117,460119.5 K to 117.5 K (-1.67 %)
May 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...SellS14.952,00029,900119,460121.5 K to 119.5 K (-1.65 %)
May 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...BuyM0.007,6980121,460113.8 K to 121.5 K (+6.77 %)
May 17 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...BuyM0.009350113,762112.8 K to 113.8 K (+0.83 %)
May 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseM0.0081702,997
May 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseM0.001,54904,645
May 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorSellS15.251,18418,056103,374104.6 K to 103.4 K (-1.13 %)
May 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorBuyM0.008170104,558103.7 K to 104.6 K (+0.79 %)
May 17 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorBuyM0.001,5490103,741102.2 K to 103.7 K (+1.52 %)
May 17 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...Option ExerciseM0.005,908015,754
May 17 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...BuyM0.005,9080731,859726 K to 731.9 K (+0.81 %)
May 17 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...Option ExerciseM0.0082902,211
May 17 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...SellS14.997,604113,984374,080381.7 K to 374.1 K (-1.99 %)

View all Atara Biotherapeutics, Inc. insider transactions.